Severe insulin resistance treated with insulin lispro [13]

Lancet

Volumn 348, Issue 9036, 1996, Pages 1248-

  Henrichs, H R ^a   Unger, H ^a   Trautmann, M E ^a   Pfutzner, A ^a  

^a LILLY DEUTSCHLAND GMBH   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

GLUCOSE; INSULIN; INSULIN DERIVATIVE; INSULIN LISPRO;

ADULT; BODY WEIGHT; CASE REPORT; COLON PERFORATION; DIABETES MELLITUS; DRUG ABSORPTION; DRUG EFFICACY; FEMALE; GLUCOSE BLOOD LEVEL; HUMAN; INSULIN DEPENDENT DIABETES MELLITUS; INSULIN RESISTANCE; INTRAMUSCULAR DRUG ADMINISTRATION; INTRAPERITONEAL DRUG ADMINISTRATION; INTRAVENOUS DRUG ADMINISTRATION; KETOACIDOSIS; LETTER; PRIORITY JOURNAL; SUBCUTANEOUS DRUG ADMINISTRATION;

EID: 0029846888     PISSN: 01406736     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0140-6736(05)65529-8     Document Type: Letter

References (5)

1. WC Duckworth CD Saudek RR Henry Why intraperitoneal delivery of insulin with implantable pumps in NIDDM? Diabetes 41 1992 657 661
2. DC Howey RR Bowsher RL Brunelle JR Woodworth [Lys(B28), Pro(B29)]-human insulin: a rapidly absorbed analogue of human insulin. Diabetes 43 1994 396 402
3. JH Anderson RL Brunelle L Vignati Insulin lispro compared to regular insulin in a crossover study involving 1037 patients with type 1 diabetes. Diabetes 44 suppl 1 1995 834
4. L Vignati RL Brunelle Treatment of 722 patients with type II diabetes with insulin lispro in a 6 month crossover study Diabetes 44 suppl 1 1995 840
5. AB Goldfine CR Kahn Insulin allergy and insulin resistance. Curr Ther Endocrinol Metab 5 1994 461 464